Notably, perturbation of FAP+ fibroblasts can inhibit CRC progression [62], inhibition of mesenchymal IL-33 signaling blocks epithelial CRC proliferation [63], and inhibition of mesenchymal TGF-βR1 signaling disrupts epithelial CRC metastases [14]. The gene discussed is IL33; the disease is colorectal carcinoma.